Economic evaluation of first-line adjuvant chemotherapies for resectable gastric cancer patients in China.

Economic evaluation of first-line adjuvant chemotherapies for resectable gastric cancer patients in China.

First-line postoperative adjuvant chemotherapies with S-1 and capecitabine and oxaliplatin (XELOX) were first recommended for resectable gastric cancer patients in the 2010 and 2011 Chinese NCCN Clinical Practice Guidelines in Oncology: Gastric Cancer; however, their economic impact in China is unkn...

Full description

Bibliographic Details
Main Authors:	Chongqing Tan, Liubao Peng, Xiaohui Zeng, Jianhe Li, Xiaomin Wan, Gannong Chen, Lidan Yi, Xia Luo, Ziying Zhao
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3858361?pdf=render

Similar Items

Cost-Effectiveness of ramucirumab plus paclitaxel as a second-line therapy for advanced gastric or gastro-oesophageal cancer in China.
by: Sini Li, et al.
Published: (2020-01-01)

Cost-effectiveness analysis of adding ramucirumab to the first-line erlotinib treatment for untreated EGFR-mutated metastatic non-small cell lung cancer in China
by: Xiaohui Zeng, et al.
Published: (2020-11-01)

Economic outcomes of maintenance gefitinib for locally advanced/metastatic non-small-cell lung cancer with unknown EGFR mutations: a semi-Markov model analysis.
by: Xiaohui Zeng, et al.
Published: (2014-01-01)

A trial-based cost-effectiveness analysis of erlotinib alone versus platinum-based doublet chemotherapy as first-line therapy for Eastern Asian nonsquamous non-small-cell lung cancer.
by: Siying Wang, et al.
Published: (2013-01-01)

First-Line Chemo-Immunotherapy for Extensive-Stage Small-Cell Lung Cancer: A United States-Based Cost-Effectiveness Analysis
by: Qiao Liu, et al.
Published: (2021-06-01)

Benefit of Adjuvant Traditional Herbal Medicine With Chemotherapy for Resectable Gastric Cancer
by: Yu Kyung Lee BA, et al.
Published: (2018-09-01)

Optimal duration of fluorouracil-based adjuvant chemotherapy for patients with resectable gastric cancer.
by: Jing-lei Qu, et al.
Published: (2013-01-01)

Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS)
by: van Grieken Nicole CT, et al.
Published: (2011-08-01)

Adjuvant chemotherapy for gastric cancer
by: I. P. Kolesnyk, et al.
Published: (2015-12-01)

Neoadjuvant Chemotherapy and Adjuvant Chemoradiation Therapy in the Treatment of Resected Gastric Adenocarcinoma: A Case Series
by: Christina Hadzitheodorou, et al.
Published: (2017-04-01)

Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab for Advanced Non-Small-Cell Lung Cancer
by: Xiaomin Wan, et al.
Published: (2021-08-01)

Precision medicine for adjuvant chemotherapy of resected colorectal cancer
by: Yuji Miyamoto, et al.
Published: (2020-11-01)

Perineural Invasion and Postoperative Adjuvant Chemotherapy Efficacy in Patients With Gastric Cancer
by: Qing Tao, et al.
Published: (2020-04-01)

The Aetiology of Delay to Commencement of Adjuvant Chemotherapy following Colorectal Resection
by: G. S. Simpson, et al.
Published: (2014-01-01)

TEYSUNO: FIRST-LINE CHEMOTHERAPY FOR PATIENTS WITH DISSEMINATED GASTRIC CANCER
by: O. O. GORDEEVA, et al.
Published: (2017-06-01)

Genetic polymorphisms of vascular endothelial growth factor (VEGF) associated with gastric cancer recurrence after curative resection with adjuvant chemotherapy
by: Yeon-Ji Kim, et al.
Published: (2019-05-01)

Time-related improvement of survival in resectable gastric cancer: the role of Japanese-style gastrectomy with D2 lymphadenectomy and adjuvant chemotherapy
by: Vidal Oscar, et al.
Published: (2006-08-01)

Early recurrence of pancreatic cancer after resection and during adjuvant chemotherapy
by: Richard Fischer, et al.
Published: (2012-01-01)

Is perioperative chemotherapy effective in patients with resectable gastric cancer?
by: José Peña, et al.
Published: (2014-08-01)

THE ROLE OF ADJUVANT CHEMOTHERAPY IN THE TREATMENT OF LOCALLY ADVANCED GASTRIC CANCER
by: A. A. Bobryshev, et al.
Published: (2021-03-01)

CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
by: Astrid E. Slagter, et al.
Published: (2018-09-01)

A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy
by: Qian J, et al.
Published: (2016-02-01)

Adjuvant Chemotherapy for Patients with Stage Ⅱ Colon Cancer after Resection Surgery
by: Pei-Chen Pan, et al.
Published: (2019)

Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer
by: Hyera Kim, et al.
Published: (2020-01-01)

Feasibility Study of Adjuvant Chemotherapy with Carboplatin and Nab-Paclitaxel for Completely Resected NSCLC
by: Katsurada N, et al.
Published: (2020-02-01)

Neo-adjuvant chemotherapy in stage IIIC potentially resectable epithelial ovarian cancer
by: Ioannis A. Voutsadakis
Published: (2017-05-01)

Preliminary Results of Hyperthermic Intraperitoneal Intraoperative Chemotherapy as an Adjuvant in Resectable Pancreatic Cancer
by: Antonios-Apostolos K. Tentes, et al.
Published: (2012-01-01)

Efficacy of Adjuvant Chemotherapy after Neoadjuvant FOLFIRINOX and Following Resection of Pancreatic Cancer
by: Huapyong Kang
Published: (2021-02-01)

Multicentre study of perioperative versus adjuvant chemotherapy for resectable colorectal liver metastases
by: M.‐A. Allard, et al.
Published: (2019-10-01)

Prognostic value of ESR2 expression on adjuvant chemotherapy in completely resected NSCLC.
by: Hongliang Yu, et al.
Published: (2020-01-01)

Adjuvant chemotherapy for elderly patients with gastric cancer after D2 gastrectomy.
by: Ying Jin, et al.
Published: (2013-01-01)

S-1-based chemotherapy versus capecitabine-based chemotherapy as first-line treatment for advanced gastric carcinoma: a meta-analysis.
by: Ming-ming He, et al.
Published: (2013-01-01)

Adjuvant chemoradiotherapy versus adjuvant chemotherapy for patients with N3 gastric cancer after D2/R0 resection: a retrospective study based on propensity score analyses
by: Zhou ML, et al.
Published: (2019-05-01)

Is adjuvant chemotherapy necessary in pT1N1 gastric cancer?
by: Hyun Beak Shin, et al.
Published: (2017-04-01)

Resected Pancreatic Cancer With N2 Node Involvement Is Refractory to Gemcitabine-Based Adjuvant Chemotherapy
by: Chen Liu MD, PhD, et al.
Published: (2020-04-01)

Results of combination treatment using docetaxel in an adjuvant chemotherapy regimen for resectable breast cancer
by: L. V. Bolotina, et al.
Published: (2014-07-01)

Adjuvant Chemotherapy in Resected Lung Cancer: Two-Year Experience in a University Hospital
by: Nicole Bouchard, et al.
Published: (2008-01-01)

Correction to: Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer
by: Hyera Kim, et al.
Published: (2020-07-01)

Biomarkers for efficacy of adjuvant chemotherapy following complete resection in NSCLC stages I–IIIA
by: Sandra Wallerek, et al.
Published: (2015-06-01)

Adrenocortical Carcinoma in an Adult: Eight Months without Recurrence after Resection and Adjuvant Chemotherapy
by: Marcos Duarte Siosaki, et al.
Published: (2014-03-01)